Article Details

Hansa Biopharma announces it has confidentially submitted a draft registration statement on ...

Retrieved on: 2021-11-08 08:43:32

Tags for this article:

Click the tags to see associated articles and topics

Hansa Biopharma announces it has confidentially submitted a draft registration statement on .... View article details on hiswai:

Excerpt

LUND, Sweden, Nov. 8, 2021 /PRNewswire/ -- Hansa Biopharma AB "Hansa", (Nasdaq Stockholm: HNSA), the pioneer in enzyme technology for rare ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up